# Safety Study of Calcineurin-Inhibitor-Free Immunosuppression After Liver Transplantation

> **NCT00890253** · PHASE2 · UNKNOWN · sponsor: **Armin Goralczyk** · enrollment: 29 (estimated)

## Conditions studied

- Liver Transplantation
- Chronic Renal Insufficiency

## Interventions

- **DRUG:** Basiliximab (Simulect)
- **DRUG:** Myfortic
- **DRUG:** everolimus
- **DRUG:** Prednisolone

## Key facts

- **NCT ID:** NCT00890253
- **Lead sponsor:** Armin Goralczyk
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-01
- **Primary completion:** 2012-01
- **Final completion:** 2013-01
- **Target enrollment:** 29 (ESTIMATED)
- **Last updated:** 2011-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00890253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00890253, "Safety Study of Calcineurin-Inhibitor-Free Immunosuppression After Liver Transplantation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00890253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*